Pfizer has announced its reorganization strategy with Wyeth. The research operations will be broken into two units: a biotechnology unit led by a Wyeth senior executive, and a pharmaceutical group led by a Pfizer scientist. The plan hopes to smoothly integrate Pfizer and Wyeth after the acquisition closes later this year. The Wyeth acquisition has Continue Reading …
Merck Puts Some of Their Gardasil Cash To Work
March 18, 2009 By Leave a Comment
Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a promising drug designed to prevent blood clotting. In addition, Merck will benefit from the Continue Reading …
Supreme Court To Consider Federal Pre-Emption In Wyeth V. Levine
November 4, 2008 By Leave a Comment
The U.S. Supreme Court next week will begin hearing the case of Wyeth v. Levine, which centers on the question of whether FDA approval of a drug warning label pre-empts product safety suits brought in state courts, the Wall Street Journal reports (Mundy/Wang, Wall Street Journal, 10/27). The case involves Diana Levine, who lost her Continue Reading …
Follow Us!